Arich Enterprise Co., Ltd. (TPEX:4173)
17.95
-0.10 (-0.55%)
Jul 14, 2026, 1:24 PM CST
Arich Enterprise Revenue
Arich Enterprise had revenue of 411.38M TWD in the quarter ending March 31, 2026, with 4.46% growth. This brings the company's revenue in the last twelve months to 1.56B, up 13.40% year-over-year. In the year 2025, Arich Enterprise had annual revenue of 1.55B with 19.20% growth.
Revenue (ttm)
1.56B
Revenue Growth
+13.40%
P/S Ratio
0.86
Revenue / Employee
7.90M
Employees
198
Market Cap
1.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.55B | 249.23M | 19.20% |
| Dec 31, 2024 | 1.30B | 157.69M | 13.83% |
| Dec 31, 2023 | 1.14B | 122.06M | 11.99% |
| Dec 31, 2022 | 1.02B | 72.36M | 7.65% |
| Dec 31, 2021 | 945.66M | -305.73M | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 17.50B |
| Bioptik Technology Incorporation | 865.76M |
| GeneFerm Biotechnology | 663.87M |
| Lagis Enterprise | 486.50M |
| GenMont Biotech Incorporation | 390.95M |
| NeoCore Technology | 235.54M |
| InnoPharmax | 68.99M |
| Caliway Biopharmaceuticals | 38.04M |